Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald A Berry

Showing results (31-40 of 197) with videos related to

Pageof 20
Sort By:
JAMA Surgery|July 27, 2018
Concern Regarding Age Distribution of Breast CancerKathleen A Cronin, Donald A Berry
Biometrics|June 8, 2004
Accounting for multiplicities in assessing drug safety: a three-level hierarchical mixture modelScott M Berry, Donald A Berry
Journal of the National Cancer Institute|November 12, 2009
Detecting an overall survival benefit that is derived from progression-free survivalKristine R Broglio, Donald A Berry
JAMA Oncology|July 17, 2015
Neoadjuvant Therapy in Breast Cancer as a Basis for Drug ApprovalDonald A Berry, Clifford A Hudis
Journal of the National Cancer Institute|July 27, 2007
Breast cancer trends: a marriage between clinical trial evidence and epidemiologyDonald A Berry, Peter M Ravdin
BMC Genetics|February 3, 2006
A new Bayesian approach incorporating covariate information for heterogeneity and its comparison with HLODSwati Biswas, Shili Lin, Donald A Berry
Clinical Trials (London, England)|November 12, 2005
Bayesian predictions of final outcomes: regulatory approval of a spinal implantBailey Lipscomb, Guorong Ma, Donald A Berry
Stroke|May 10, 2005
The past is the future: innovative designs in acute stroke therapy trialsMichael Krams, Kennedy R Lees, Donald A Berry
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2012
Reports from the 2010 Clinical and Translational Cancer Research Think Tank meeting: design strategies for personalized therapy trialsDonald A Berry, Roy S Herbst, Eric H Rubin
Trials|March 11, 2014
Predicting clinical trial results based on announcements of interim analysesKristine R Broglio, David N Stivers, Donald A Berry
Pageof 20

Showing results (31-40 of 197) with videos related to

Sort By:
Pageof 20
JAMA Surgery|July 27, 2018
Concern Regarding Age Distribution of Breast CancerKathleen A Cronin, Donald A Berry
Biometrics|June 8, 2004
Accounting for multiplicities in assessing drug safety: a three-level hierarchical mixture modelScott M Berry, Donald A Berry
Journal of the National Cancer Institute|November 12, 2009
Detecting an overall survival benefit that is derived from progression-free survivalKristine R Broglio, Donald A Berry
JAMA Oncology|July 17, 2015
Neoadjuvant Therapy in Breast Cancer as a Basis for Drug ApprovalDonald A Berry, Clifford A Hudis
Journal of the National Cancer Institute|July 27, 2007
Breast cancer trends: a marriage between clinical trial evidence and epidemiologyDonald A Berry, Peter M Ravdin
BMC Genetics|February 3, 2006
A new Bayesian approach incorporating covariate information for heterogeneity and its comparison with HLODSwati Biswas, Shili Lin, Donald A Berry
Clinical Trials (London, England)|November 12, 2005
Bayesian predictions of final outcomes: regulatory approval of a spinal implantBailey Lipscomb, Guorong Ma, Donald A Berry
Stroke|May 10, 2005
The past is the future: innovative designs in acute stroke therapy trialsMichael Krams, Kennedy R Lees, Donald A Berry
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2012
Reports from the 2010 Clinical and Translational Cancer Research Think Tank meeting: design strategies for personalized therapy trialsDonald A Berry, Roy S Herbst, Eric H Rubin
Trials|March 11, 2014
Predicting clinical trial results based on announcements of interim analysesKristine R Broglio, David N Stivers, Donald A Berry
Pageof 20